Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    10816186 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Natural History of Levodopa-Induced Dyskinesia (LID)
Condition: Parkinson's Disease
Intervention: Drug: Levodopa (delivered intravenously)
2 Recruiting Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
Condition: Parkinson's Disease
Interventions: Drug: Docosahexaenoic Acid (DHA);   Drug: Placebo
3 Recruiting Comparison of the Incidence of Dyskinesia in Parkinson`s Disease Who Were Treated With Amantadine or Dopamine Agonist
Condition: Parkinson`s Disease
Intervention:

Indicates status has not been verified in more than two years